Alan Louis Urban - 14 Mar 2023 Form 4 Insider Report for SRAX, Inc. (SRAX)

Role: Chief Financial Officer
Signature: /s/ Alan Louis Urban
Issuer symbol: SRAX
Transactions as of: 14 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Mar 2023, 14:57:48 UTC
Previous filing: 19 Jul 2022
Next filing: 13 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRAX	Class A Common Stock Purchase Option	Award	$0	+300,000		$0.000000	300,000	14 Mar 2023	Class A Common Stock	300,000	$0.4400	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant").
F2	The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control.

Content

Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant").

The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control.